Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KIAA1614 encodes a large, uncharacterized human protein predicted to be involved in the centrosome cycle, cell polarity, and regulation of cellular localization[1][6]. It is a protein-coding gene but lacks characterization of biological function or molecular pathways and has no known role as a therapeutic target, drug-interacting partner, or biomarker. KIAA1614 is associated in genome-wide studies with syndromic diseases such as Fanconi anemia and X-linked hypoparathyroidism, but no direct functional mechanisms are established[1][4]. Its expression is detectable in several tissues, and while it is a candidate locus for novel genetic syndromes, there is no evidence for direct therapeutic relevance at this time. The protein is uncharacterized in terms of druggability, clinical biomarkers, or established safety concerns[1][4][6][8][11].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Uncharacterized protein KIAA1614 (KIAA1614).